Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Semaglutide 2.4 mg in adults with overweight or obesity: A randomized, double-blind, placebo-controlled trial
Is there a role for glucagon-like peptide-1 receptor agonists
Always freeze lyophilized vials immediately upon receipt
Eli Lilly (NYSE: LLY) saw its shares climb 5% this past week after announcing that its history-making oral obesity candidate, orforglipron aced the Phase III ATTAIN-2 trial (NCT05872620), which assessed the small molecule glucagon-like peptide-1 (GLP-1) receptor agonist in adults who were obese or overweight and had type 2 diabetes
GLP-1s also make some people feel more tired
And obesity is a chronic disease, she says, so some patients like Woodard may need multiple strategies to help manage their condition including surgery, diet, exercise and GLP-1s
US$ 28.91
)
US$ 26.00
US$ 25.75
